Learn the key differences between sustained and prolonged release tablets, their mechanisms, advantages, and clinical uses. A complete guide to modified drug delivery systems in pharmaceutics.
In modern pharmaceutics, the goal is no longer just developing new drug molecules—it’s about maximizing therapeutic effectiveness while minimizing side effects. Controlled drug delivery systems have revolutionized treatment outcomes, and among them, Sustained Release (SR) and Prolonged Release (PR) tablets play a critical role.
Sustained and Prolonged are modified release tablets having different properties in their drug release timings and have considerable differences. Although these terms are often used interchangeably, they differ significantly in their release kinetics, formulation strategies, and clinical outcomes.
This guide breaks down their principles, mechanisms, advantages, and key differences in a clear, practical way.
Introduction to Modified Release Dosage Forms
Immediate-release formulations deliver drugs rapidly after administration, often causing sharp peaks in plasma concentration. This can lead to side effects and requires frequent dosing.
To overcome these issues, modified release dosage forms were developed. These systems are designed to control the rate, timing, and site of drug release.
Types of Modified Release Systems:
- Delayed Release (DR): Drug release after a lag time (e.g., enteric-coated tablets)
- Extended Release (ER): Drug release over an extended period
- Sustained Release (SR): Maintains a constant drug level for a defined period
- Prolonged Release (PR): Extends drug action without strict control over release rate
Both SR and PR fall under extended-release systems—but their therapeutic intent differs.
What are Sustained Release Tablets?
Sustained release tablets are designed to deliver a drug at a controlled and predictable rate, maintaining a constant plasma concentration within the therapeutic window.
Mechanisms of Sustained Release
- Diffusion-controlled systems: Drug diffuses through a polymer matrix
- Erosion-controlled systems: Matrix gradually erodes to release drug
- Osmotic systems: Drug is pushed out via osmotic pressure
- Ion-exchange resins: Release depends on ionic interactions
Key Characteristics
- Controlled and uniform drug release
- Maintains steady plasma concentration
- Reduces dosing frequency (1–2 times daily)
- Minimizes peaks and troughs
Example: Theophylline SR tablets for asthma (12–24 hour action)
What are Prolonged Release Tablets?
Prolonged release tablets are designed to extend the duration of drug action, but they do not strictly control the release rate or maintain constant plasma levels.
Mechanisms of Prolonged Release
- Polymer coatings: Slow down drug dissolution
- Matrix systems: Gradual disintegration or dissolution
Key Characteristics
- Extends therapeutic effect duration
- Plasma levels may fluctuate
- Suitable for short half-life drugs
- Reduces dosing frequency
Example: Diclofenac PR tablets for prolonged anti-inflammatory effect
Difference Between Sustained and Prolonged Release Tablets
| Feature | Sustained Release (SR) | Prolonged Release (PR) |
|---|---|---|
| Purpose | Maintain constant drug levels | Extend duration of action |
| Release Rate | Controlled and uniform | Gradual, not necessarily uniform |
| Plasma Levels | Stable within therapeutic window | May fluctuate |
| Mechanism | Diffusion, erosion, osmotic | Slow dissolution/disintegration |
| Therapeutic Goal | Consistent effect | Longer effect duration |
| Dosing Frequency | Once or twice daily | Once daily or less |
| Suitable Drugs | Moderate half-life | Short half-life |
Advantages of SR and PR Tablets
For Patients
- Reduced dosing frequency
- Improved compliance
- Fewer side effects
- Better management of chronic diseases
For Manufacturers
- Product differentiation
- Extended product lifecycle
- Opportunities for patent protection
For Healthcare Systems
- Improved treatment outcomes
- Reduced hospitalizations
- Better patient adherence
Disadvantages and Challenges
Despite their benefits, SR and PR systems come with challenges:
- Complex manufacturing processes
- Risk of dose dumping
- Variable absorption due to GI conditions
- Higher development cost
- Strict regulatory requirements
Design Considerations for Modified Release Tablets
Formulation scientists must consider:
- Drug physicochemical properties
- Half-life and stability
- Therapeutic window
- Absorption site
- Desired release duration (8, 12, 24 hours)
Common Technologies Used
- Hydrophilic matrices: HPMC, Xanthan gum
- Hydrophobic matrices: Ethyl cellulose, waxes
- Coating systems: Eudragit, cellulose acetate
- Multiparticulate systems: Pellets, microcapsules
Pharmacokinetic Profiles
- Sustained Release: Flat plasma concentration curve (steady-state)
- Prolonged Release: Gradual decline curve (extended action)
Understanding these profiles is essential for bioequivalence studies and formulation design.
Applications of SR and PR Tablets
These formulations are widely used in chronic conditions such as:
- Hypertension
- Diabetes
- Asthma
- Pain management
- Psychiatric disorders
They significantly improve patient convenience and treatment adherence.
Frequently Asked Questions (FAQs)
1. What is the main difference between sustained and prolonged release tablets?
Sustained release tablets maintain a constant drug level, while prolonged release tablets extend the duration of drug action without strict control over plasma concentration.
2. Are sustained and prolonged release tablets the same?
No, both are modified release systems but differ in release control and therapeutic objectives.
3. How do sustained release tablets work?
They use mechanisms like diffusion, erosion, or osmotic pressure to release drugs at a controlled rate.
4. What is the benefit of prolonged release tablets?
They reduce dosing frequency by extending the drug’s effect over a longer period.
5. Which drugs are suitable for sustained release formulations?
Drugs with moderate half-lives and wide therapeutic windows are ideal candidates.
6. Can all drugs be made into sustained release tablets?
No, drugs with narrow therapeutic index or very short/long half-lives may not be suitable.
7. Do prolonged release tablets maintain constant plasma levels?
No, plasma levels may fluctuate but remain within effective limits.
8. What are the risks associated with modified release tablets?
The main risk is dose dumping, which can lead to toxicity.
9. Why are modified release formulations more expensive?
They require complex formulation, advanced technology, and extensive testing.
10. What is the role of polymers in sustained release tablets?
Polymers control drug release by forming matrices or coatings that regulate diffusion and dissolution.